Official Organ of
Affiliated with Official Organ of the
European Association for the Study of Obesity Editorial Representatives
Hermann Toplak, Graz
Deutsche Adipositas-Gesellschaft Editorial Representative Matthias Blüher, Leipzig
International Federation for the Surgery of Obesity and Metabolic Disorders – European Chapter Editorial Representative
Editor-in-Chief
Hans Hauner, MD – Else Kroener-Fresenius Center for Nutritional Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Assistant Editor
Nora Klöting, MD – Integrated Research and Treatment Center (IFB) Adiposity Diseases, University of Leipzig, Leipzig, Germany
Associate Editors
Jennifer Lyn Baker, MD – Institute of Preventive Medicine, Frederiksberg Hospital, Frederiksberg, Denmark
Ellen E. Blaak, MD – Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands Matthias Blüher, MD – Department of Medicine, Endocrinology and Diabetes, University of Leipzig,
Leipzig, Germany
John E. Blundell, PhD – School of Psychology, Faculty of Medicine and Health, University of Leeds, Leeds, UK
Karine Clément, MD – Institute of Cardiometabolism and Nutrition, Assistance Publique-Hôpitaux de Paris, Pitié-Salpétrière Hospital, Paris, France
Carl-Erik Flodmark, MD – Department of Pediatrics, Skåne University Hospital Malmö, Malmö, Sweden
Martin Fried, MD – OB Klinika – Centre for Treatment of Obesity and Metabolic Disorders, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
Vojtech Hainer, MD – Obesity Management Centre, Institute of Endocrinology, Prague, Czech Republic
Berit L. Heitmann, MD – Research Unit for Dietary Studies, The Parker Institute, Frederiksberg Hospital, Copenhagen, Denmark
Anja Hilbert, PhD – Integrated Research and Treatment Center (IFB) AdiposityDiseases, Behavioral Medicine, University of Leipzig, Leipzig, Germany
Anke Hinney, PhD – Department of Child and Adolescent Psychiatry, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Christina Holzapfel, PhD – University Hospital Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
John G. Kral, MD – Department of Surgery, SUNY Downstate Medical Center, Brooklyn, NY, USA Lauren Lissner, MD – Department of Public Health and Community Medicine, Institute of Medicine,
Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Bernhard Ludvik, MD – Department of Medicine 1, Rudolfstiftung Hospital, Vienna, Austria Dragan Micic, MD – School of Medicine, University of Belgrade, Belgrade, Serbia
Manfred J. Müller, MD – Institute of Human Nutrition and Food Science, Faculty of Agricultural and Nutritional Sciences, Christian-Albrechts-University, Kiel, Germany
Founding Editor: Johannes Hebebrand, Essen
Peking University, Beijing, China
Kurt Widhalm, MD – Austrian Academic Institute for Clinical Nutrition, Vienna, Austria Tommy Visscher, PhD – Windesheim University of Applied Sciences, Zwolle, The Netherlands Editorial Board Members
Hans-Rudolf Berthoud, MD – Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA, USA
Stefan Engeli, MD – Institute for Clinical Pharmacology, Hanover Medical School, Hanover, Germany Gema Frühbeck, MD, PhD – Department of Endocrinology and Nutrition, Clínica Universidad de
Navarra, University of Navarra, CIBEROBN, IdiSNA, Pamplona, Spain
Susanna Hofmann, MD – Helmholtz Center Munich, Institute of Diabetes and Regeneration Research, Neuherberg, Germany
Martin Klingenspor, MD – Chair of Molecular Nutritional Medicine, Else Kröner-Fresenius Center, Technical University of Munich, Freising-Weihenstephan, Germany
Julian G. Mercer, MD – The Rowett Institute, University of Aberdeen, Foresterhill, UK Vidya Mohamed-Ali, MD – Adipokines and Metabolism Research Group, Centre for Clinical
Pharmacology, BHF Labs University College London, London, UK
Dénes Molnár, MD – Department of Pediatrics, University of Pécs Medical School, Pécs, Hungary Rubén Nogueiras, MD – Department of Physiology, School of Medicine, University of Santiago de
Compostela, Santiago de Compostela, Spain
Jean-Michel Oppert, MD – Department of Nutrition, Pitié-Salpétrière Hospital (AP-HP), Paris, France Andreas F.H. Pfeiffer, MD – Department of Clinical Nutrition, German Institute of Human Nutrition
Potsdam- Rehbruecke, Nuthetal, Germany
Paul T. Pfluger, MD – Helmholtz Diabetes Center and Helmholtz Pioneer Campus, Helmholtz Zentrum München, German Center for Diabetes Research (DZD), Technical University of Munich, Neuherberg, Germany
Gabriela Roman, MD, PhD – Clinical Center of Diabetes, Nutrition, Metabolic Diseases,
‘Iuliu Hatieganu’ University of Medicine & Pharmacy, Cluj-Napoca, Romania
Stephan Rössner, MD – Professor emeritus, Karolinska Institutet, Apple Bay Obesity Research Centre, Bromma, Sweden
Jacob C. Seidell, PhD – Department of Health Sciences, Faculty of Earth and Life Sciences, VU University Amsterdam, Amsterdam, The Netherlands
Antonio J. Torres, MD – Department of Surgery, Hospital Clinico San Carlos, Complutense University of Madrid, Madrid, Spain
Christian Vaisse, MD, PhD – Diabetes Center and Department of Medicine, University of California San Francisco, San Francisco, CA, USA
Philippe Valet, PhD – Institut des Maladies Metaboliques et Cardiovasculaires, I2MC, Inserm – University Paul Sabatier UMR 1048, Toulouse, France
Volkan Demirhan Yumuk, MD – Division of Endocrinology, Metabolism and Diabetes, Istanbul University Cerrahpaşa Medical Faculty, Istanbul, Turkey
26th European Congress on Obesity
Glasgow, UK, 28 April – 01 May, 2019
ABSTRACTS
Vol. 12, Suppl. 1, 2019
Trustees
President: Nathalie Farpour-Lambert, Switzerland President-Elect & Treasurer: Jason Halford, UK Secretary: Ellen Blaak, Netherlands
Vice-President Northern Region: Jørn Sagen, Norway
Vice-President Middle Region: Dana Mullerova, Czech Republic Vice-President Southern Region: Volkan Yumuk, Turkey
Ex-Officio
Co-Chair, Childhood Obesity Task Force: Jennifer Baker, Denmark Co-Chair, Childhood Obesity Task Force: Jens-Christian Holm, Denmark Co-Chair, Obesity Management Task Force: Luca Busetto, Italy
Co-Chair, Obesity Management Task Force: Dror Dicker, Israel Co-Chair, Prevention and Public Health Task Force: Harry Rutter, UK
Co-Chair, Prevention and Public Health Task Force: Susanna Lehtinen-Jacks, Finland Co-Chair: Nutrition Working Group: Maria Hassapidou, Greece
Co-Chair: Nutrition Working Group: Teodora Handjieva-Darlenska, Bulgaria Co-Chair, Scientific Advisory Board: Gema Frühbeck, Spain
Co-Chair, Scientific Advisory Board: Gijs Goossens, Netherlands Executive Director: Euan Woodward, UK
Programme Organising Committee (POC) Jennifer Baker, Denmark
Ellen Blaak, Netherlands Maria Bryant, UK Luca Busetto, Italy Emilie Combet, UK Dror Dicker, Israel
Nathalie Farpour-Lambert, Switzerland Graham Finlayson, UK
Gema Frühbeck, Spain Gijs Goossens, Netherlands Jason Halford, UK
Nicola Heslehurst, UK Jens-Christian Holm, Denmark Mike Lean, UK
Anne Martin, UK
Dana Mullerova, Czech Republic Harry Rutter, UK
Jørn Sagen, Norway Abd Tahrani, UK Hermann Toplak, Austria Simon Williams, UK Euan Woodward, UK Volkan Yumuk, Turkey
EASO Executive Committee
Vol. 12, Suppl. 1, 2019
PLENARY LECTURES
Monday, 29 April 2019
PL2 – Precision Nutrition 1
PL3 – What Is an Effective Treatment Outcome? 1
Tuesday, 30 April 2019
PL5 – Obesity as a Disease Process 1
PL6 – Healthy Adipocyte 2
PL7 – Drive and Ambition in an Appetite Control System – An Update 2 PL8 – Diet, Body Weight Management and Cardiometabolic Risk 2
INTEGRATIVE SESSIONS
Sunday, 28 April 2019
IS1 – Gender Differences in Obesity 3
IS2 – Physical Activity and Sedentary Behaviour 4
IS3 – Effects of Obesity Treatment on Complications 6
IS4 – Inter-Organ Crosstalk 6
IS5 – Innovative Approaches – Drugs and Devices 8
IS6 – Pregnancy and Post-Partum 9
Monday, 29 April 2019
IS8 – Innovative Approaches – Digital Technology 10
IS10 – Meal Timing 11
IS11 – Joint Session with ESPEN: Obesity in the Elderly 12
IS12 – Weight Management as a Treatment for Diabetes 13
Tuesday, 30 April 2019
IS13 – Chronobiology 14
IS14 – Stress and Eating Behaviour 16
IS15 – Microbiota – from Mouth to Gut 18
Wednesday, 01 May 2019
IS16 – Immunometabolism 19
IS17 – Endocrine Disruptors and Obesity 20
IS19 – Adipose Tissue Biology 20
IS20 – Appetite Regulation, Reward & Control 21
IS21 – Vulnerable Populations and Childhood Obesity 23
ACCEPTED SYMPOSIUM
Sunday, 28 April 2019
AS1 – Tackling Obesity through Manipulating Energy Intake 25
AS2 – NoHoW EU Project 26
Monday, 29 April 2019
AS3 – Total Diet Replacement Programmes for Weight loss – from Research
to Practice 26
AS4 – Socioeconomic Differences in Overweight: Examining Environmental
and Psychological Mechanisms 26
AS5 – Emotion Regulation: Psychological, Behavioural and Biological Pathways
to Overweight in Youth 27
AS6 – The ToyBox Kindergarten/Nursery Intervention to Prevent Obesity in Pre-School Children: Impact, Experiences & Outcomes, and
Translation across Europe, Malaysia and Scotland 28
Contents
OS1 – Adipose Tissue Biology 31 Monday, 29 April 2019
OS2 – Consequences of Overweight in Children and Adolescents 34
OS3 – Infant, Child and Adolescent Obesity 35
OS4 – Brain/Gut in Obesity 37
OS5 – Maternal Obesity
OS6 – Lifestyle and Health 40
0S7 – Medical Management 42
Tuesday, 30 April 2019
OS8 – Food Environment 45
Wednesday, 01 May 2019
OS9 – Bariatric Surgery 47
POSTER PITCH SESSIONS
Tuesday, 30 April 2019
PP1 – Basic and Experimental Science 50
PP2 – Childhood and Adolescent Obesity 54
PP3 – Health, Behaviour and Environment 57
PP4 – Management and Intervention 60
CHAIRED POSTERS
Monday, 29 April 2019
CP1 – Basic and Experimental Science & Management and Intervention 65 CP2 – Childhood and Adolescent Obesity & Health, Behaviour and Environment 72
POSTERS BY TRACKS
Monday, 29 April 2019
PO1 – Basic and Experimental Science 79
PO1 – Childhood and Adolescent Obesity 105
PO1 – Health, Behaviour and Environment 126
PO1 – Management and Intervention 153
Tuesday, 30 April 2019
PO2 – Basic and Experimental Science 180
PO2 – Childhood and Adolescent Obesity 205
PO2 – Health, Behaviour and Environment 221
PO2 – Management and Intervention 246
Author Index 275
Journal Information
Aims and Scope
‘Obesity Facts’ publishes articles covering all aspects of obesity, in particular epidemiology, etiology and pathogenesis, treatment, and the prevention of adiposity. As obesity is related to many disease processes, the journal is also dedicated to all topics pertaining to comorbid- ity and covers psychological and sociocultural aspects as well as influences of nutrition and exercise on body weight. The editors carefully select papers to present only the most recent findings in clinical practice and research. All professionals concerned with obesity issues will find this journal a most valuable update to keep them abreast of the latest scientific devel- opments.
Special sections comprising a variety of subspecialties reinforce the journal’s value as an ex- haustive record of recent progress for all internists, gastroenterologists, endocrinologists, pediatricians, dieticians, nutritionists, bariatric surgeons, psychologists and psychiatrists, oc- cupational health practitioners, sports medicine specialists, ecotrophologists, sociologists, and biologists as well as prevention and public health researchers. In addition, ‘Obesity Facts’
serves as an ideal information tool for the members of the pharmaceutical and food industry as well as those active in nutritional research and medicine.
ISSN Print Edition: 1662–4025 ISSN Online Edition: 1662–4033 Journal Homepage: www.karger.com/ofa Bibliographic Indices: This journal is regularly listed in bibliographic services, including PubMed, MED- LINE, PubMed Central, Web of Science, Science Cita- tion Index Expanded, Current Contents, Clarivate Analytics, Google Scholar, Chemical Abstracts Ser- vice, American Chemical Society, DOAJ: Directory of Open Access Journals, FSTA: Food Science and Tech- nology Abstracts, Scopus, Embase, Pathway Studio, EMCare, WorldCat
Publication Data: Obesity Facts is published 6 times a year. Volume 12, each with 6 issues, appears in 2019.
Copyright: © 2019 S. Karger AG, Basel (Switzerland).
All rights reserved. No part of this publication may be translated into other languages, reproduced or uti- lized in any form or by any means, electronic or me- chanical, including photocopying, recording, micro- copying, or by any information storage and retrieval system, without permission in writing from the pub- lisher.
Disclaimer: The statements, opinions and data con- tained in this publication are solely those of the indi- vidual authors and contributors and not of the pub- lisher and the editor(s). The appearance of advertise- ments in the journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
S. Karger Verlag für Medizin und Naturwissenschaften GmbH Wilhelmstr. 20A
79098 Freiburg (Germany)
S. Karger AG
Medical and Scientific Publishers Allschwilerstrasse 10
CH–4009 Basel Switzerland t: +41 61 306 11 11 f: +41 61 306 12 34 e: [email protected] w: www.karger.com (for courier services only:
Allschwilerstrasse 10
Advertising: Correspondence should be addressed to the publisher.
S. Karger Verlag für Medizin und Naturwissenschaften GmbH
Attn. Ellen Zimmermann (Corporate Sales Manager) [email protected]
Price list No. 8 of January 1, 2019 is effective.
Back Volumes and Single Issues: Information on availability and prices of single print issues and print or electronic back volumes can be obtained from Customer Service at [email protected].
Guidelines for Authors
We strongly encourage authors to read the Guidelines for Authors at
www.karger.com/ofa_guidelines prior to submitting an article.
Journal Contact
For questions or comments, please contact the persons responsible who can be found at http://www.karger.com/Journal/Contact/233731.
Metabolic Syndrome consequent to Endocrine Disorders
Editors
V. Popovic M. Korbonits
The easiest way to order: w w w.karger.com/fhr
Hormonal dysfunction can have a major and often complex impact on all key components of the metabolic syndrome. This book com- prises state-of-the-art reviews on the subject written by recognized experts in the field of endocrinology. Each chapter covers specific manifestations associated with the metabolic syndrome in classic endocrine diseases. Compelling questions are highlighted and future directions presented. The topics covered include hypopitu- itarism, adrenal insufficiency, acromegaly, glucocorticoid excess, androgen excess, hypogonadism, prolactin, and thyroid and para- thyroid hormone abnormalities.
This book is meant to inspire subsequent research related to met- abolic complications in endocrine diseases, thus enabling early detection as well as prompt and appropriate management.
Contents
• Preface: Popovic, V.; Korbonits, M.
• Metabolic Syndrome in Hypopituitarism: Miljic, D.; Popovic, V.
• Metabolic Complications of Acromegaly: Mercado, M.;
Ramírez-Rentería, C.
• Metabolic Syndrome in Hyperprolactinemia: Andersen, M.;
Glintborg, D.
• Metabolic Syndrome in Thyroid Disease: Iwen, K.A.; Oelkrug, R.;
Kalscheuer, H.; Brabant, G.
• Metabolic Syndrome in Parathyroid Diseases: Corbetta, S.;
Mantovani, G.; Spada, A.
• Metabolic Syndrome in Cushing’s Syndrome Patients: Ferraù, F.;
Korbonits, M.
• Metabolic Complications in Adrenal Insufficiency: Ueland, G.A.;
Husebye, E.S.
• Metabolic Syndrome in Polycystic Ovary Syndrome: Pasquali, R.
• Metabolic Syndrome in Male Hypogonadism: Rastrelli, G.;
Filippi, S.; Sforza, A.; Maggi, M.; Corona, G.
• The Metabolic Syndrome in Central Hypogonadotrophic Hypogonadism: Dwyer, A.A.; Quinton, R.
Author Index / Subject Index
Metabolic Syndrome
Consequent to Endocrine Disorders
Editors
Vera Popovic Marta Korbonits
Metabolic Syndrome Consequent to Endocrine Disorders
Editors: Popovic, V. (Belgrade); Korbonits, M.
(London)
X + 174 p., 19 fig., 13 in color, 4 tab., 2018 CHF 148.00 / EUR 138.00 / USD 174.00 Hard cover or online prices for personal customers Prices subject to change, VAT not included EUR price for eurozone countries, USD price for USA and Latin America only
ISBN 978–3–318–06334–9 e-ISBN 978–3–318–06335–6 Frontiers of Hormone Research, Vol. 49 Series Editor: Ghigo, E.; Guaraldi, F. (Turin) ISSN 0301–3073 / e-ISSN 1662–3762 Listed in MEDLINE/PubMed
Fields of Interest: Endocrinology; Metabolism;
Diabetes, Obesity, Reproduction
Dear Librarian
I have reviewed this publication and would like to recommend it for our library.
Recommended by:
Department:
Date:
Signature:
Obes Facts 2019;12(suppl 1):1–290 Abstracts 168
PO1.216
Traditional Chinese medicine intervention based on herbal formula XRHZ may contribute to managing body weight in Chinese simple obese patients
Tao, F.1; Jin, X.1; Fei, X.2; Yang, X.1; Liu, X.1; Gao, Y.1; Liu, Z.1; Hou, R.1; Xu, P.1; Yao, Z.1; Ding, X.1
1Department of Endocrinology, Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
2Department of Nutrition, Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
Introduction: Obesity is a worldwide serious healthy issue. Recently, the prevalence of obesity increases rapidly. However, only orlistat is approved as oral anti-obesity medication by Chinese government. Traditional Chi- nese Medicine (TCM) herbal therapy has been proved effectiveness in weight management by meta analyses. It also showed some disadvantages, like short observation and low jadad score.
Methods: A 12-week randomized, double-minded, placebo-controlled study was designed to evaluate the effectiveness of a TCM intervention in simple obese patients charactered by TCM Syndrome of dampness-heat accumulation in spleen and stomach. All subjects were randomly as- signed to take XRHZ granule or placebo granule once daily. They were followed every 2 weeks by out-patient clinic, instructed by nutritionist to perform calorie-restrict diet and encouraged to adhere to 150 min- utes moderate-intensity exercise per week recorded by sports bracelet.
This study was registered in Chinese Clinical Trial Registry (No. ChiC- TR-IOR-17013779).
Results: Of the 75 subjects randomized, 68 (age 39.7±11.6 yrs, BMI 33.1±4.8 kg/m2, male 47.6%) were included in the ITT analysis. The BW, BMI, WC, fat mass index (FMi) and trunk fat mass percent (TFM%) in XRHZ group were reduced by 4.2 kg, 1.4 kg/m2, 6 cm, 1.2 kg/m2 and 2.1%, those in placebo group were reduced by 1.2 kg, 0.4 kg/m2, 2 cm, 0.2 kg/m2 and 0.7% respectively. There were significant differences in BW, BMI, WC and FMi between two groups. Adverse events were minor in both groups.
Conclusion: TCM Intervention based on herbal formula XRHZ may help Chinese simple obese patients manage body weight, waist circumstance and fat mass.
Conflict of Interest: None Disclosed.
Funding: Research relating to this abstract was funded by Shanghai Municipal health Commission(2016LQ018) and Shanghai Science and Technology Commit- tee (17401935200).
PO1.217
Adapting the ToyBox Study for application in Malaysian kindergartens
Poh, B.1; Cheah, W.2; Ruzita, A.1; Lee, J. A.2; Koh, D. C.1; Farra, A. J.1; Noor Hafizah, Y.1; Reeves, S.3; Essau, C.3; Summerbell, C.4; Gibson, E. L.3
1Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
2Universiti Malaysia Sarawak, Kota Samarahan, Malaysia
3University of Roehampton, London, UK
4University of Durham, Durham, UK
Introduction: As obesity rates continue to rise in Malaysia, early life in- tervention may be the key to preventing later life health complications.
This study was conducted to assess the feasibility of adapting a European kindergarten-based family-involved intervention programme for imple- mentation in Malaysian kindergartens.
Methods: The ToyBox Study programme aims to improve four key energy-balance related behaviours, namely drinking water, choosing healthy food and snacks, increasing physical activity, and reducing seden- tary behaviour. We conducted the project in three phases: (i) Preparation, which involved adaptation of European ToyBox-Study components into Malaysian context, (ii) Implementation, which was conducted in select- ed urban and rural kindergartens, and (iii) Evaluation, which involved assessment of feasibility and effectiveness in comparison to control kin- dergartens. Pre- and post-intervention assessments included behaviour
change, physical activity, dietary intake and health-related outcomes as measured by questionnaires, accelerometry and anthropometry.
Results: The adaptation of Toybox Study materials and questionnaires was completed in 2017, and included focus group discussions and The- ory of Change workshops with kindergarten teachers and parents of pre- schoolers. Materials were translated into the Malay language and included Malaysia-specific content, such as types of food, and context, such as the introduction of the #SukuSukuSeparuh Healthy Eating Plate. The mod- ules prepared were Teachers’ Guide, Jom Minum! (Let’s Drink!), Jom Ak- tif! (Be Active!), Makanan dan Snek Sihat (Healthy Food and Snacks), and Tingkahlaku Sedentari (Sedentary Behaviour). The feasibility study was conducted throughout year 2018 at 15 urban preschools in Kuala Lumpur and Selangor, and 7 rural ones in Sarawak, with 18 and 8 control pre- schools at the respective locations. Baseline and outcome measures were assessed at the beginning and towards the end of the 2018 school year.
Conclusion: The European ToyBox-Study programme was successfully adapted and implemented at selected kindergartens in both urban and rural Malaysia. This presentation will share some preliminary outcomes from the ToyBox Study Malaysia. We are hopeful that the ToyBox Study programme will help preschoolers and their families achieve healthier behaviours, and are optimistic that it can be sustained and be adopted by other kindergartens in Malaysia.
PO1.218
Self-monitoring behaviours among adults with obesity attending a tier 3 weight management service
Devereux, L.; Villiers-Tuthill, A.; Breen, C.; Gaynor, K.; Wallace, N.;
Meheghan, J.; O’Connell, J.; O’Shea, D.
Weight Management Service, St Columcille’s Hospital, Loughlinstown, Co. Dublin
Introduction: Self-monitoring (SM) has been identified as the founda- tion of behavioural weight loss interventions. SM in behaviour change is strongly connected to self-regulation theories and is central to this pro- cess¹. Historically, significant connections have been shown between this method, and weight-loss².
Methods: We examined the use of SM techniques in a sample of adults attending a Tier 3 Weight Management Service in two separate SM areas;
diet and self-weighing. Data was collected at baseline and 6 months as part of a standard questionnaire which asked ‘How often do you use of a food diary/tracker to monitor what you are eating’ and ‘How often do you currently weigh yourself?’. Analysis was conducted using Microsoft Excel 2010 (Microsoft, Washington, USA) and IBM SPSS Version 25.0. Data was expressed as mean ± standard deviation.
Results: Data for baseline and 6 month SM was available for n502 (62.4%
female). Mean age at baseline was 45.92±11.84 years. Mean weight at base- line was 145.69±28.28kg. Mean BMI at baseline was 51.23±8.36kg/m².
At baseline 20.3% checked weight at least once per week. At 6 months this was 34.3%.
SM weight did not differ significantly across gender (p = 0.307). How- ever, significantly less women never checked their weight compared to males (25.2% and 32% resepectively) (p = 0.026). Baseline weight was significantly higher in individuals who reported never SM their weight vs. those who SM at least once a week (149.8kg vs. 141.65kg respectively) (p = 0.006). At 6 months, more men than women never SM using a food diary (62.4% vs. 50.2% respectively), however this was not found to be statistically significant (p = 0.057).
Conclusion: This appears to be one ofthe first analyses of dietary and weighing self-monitoring techniques in adults with obesity attending a Tier 3 Weight Management Service in Ireland. It is important to raise awareness of the efficacy of self-monitoring as a weight management strategy as it may be associated with baseline weight. Reasons for not monitoring weight or food intake should be explored at the beginning of weight management programmes, as specific challenges such as access to appropriate scales or poor literacy may apply. Healthcare professionals